7 recruiting. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Recruiting 7 |
Follow Death: new trials by email Literature Review of Death trials Research Report on Death
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of High- Versus Low-Dose Aspirin for Pregnancy Outcomes in Women at High Risk of Preeclampsia Aspirin - Preeclampsia | Phase 4 | Recruiting | Medicare Hospital (Pvt) Limited | 60 | 2026-05-12 | 2026-08-21 |
| The FINTEPLA as an Anti-SUDEP Therapy in Dravet Syndrome Project Fenfluramine treatment (Fintepla), Hypercapnia Challenge using the device (RespirAct) - Dravet Syndrome | Phase 4 | Recruiting | The University of Texas Health Science Center, Houston | 25 | 2026-04-27 | 2026-07-15 |
| Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter Defibrillator Metoprolol Succinate, Carvedilol - Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death | Phase 4 | Recruiting | University of Rochester | 2000 | 2025-08-17 | 2025-09-18 |
| Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation Atorvastatin 20mg - Cerebrovascular Event, Stent Stenosis | Phase 4 | Recruiting | Duan Chuanzhi | 354 | 2024-07-30 | 2026-03-03 |
| Epinephrine Dose: Optimal Versus Standard Evaluation Trial Epinephrine - Cardiac Arrest, Out-Of-Hospital, Sudden Cardiac Arrest | Phase 4 | Recruiting | Unity Health Toronto | 1250 | 2023-05-24 | 2026-10-02 |
| Hydrocortisone Therapy Optimization During Hypothermia Treatment in Asphyxiated Neonates Hydrocortisone - Hypoxic-Ischemic Encephalopathy, Asphyxia | Phase 4 | Recruiting | Semmelweis University | 50 | 2021-09-21 | 2026-04-28 |
| Implantable Cardioverter Defibrillator Versus Optimal Medical Therapy In Patients With Variant Angina Manifesting as Aborted Sudden Cardiac Death Implantable Cardioverter Defibrillator, Optimal Medical Therapy - Angina Pectoris, Variant, Sudden Cardiac Death | Phase 4 | Recruiting | Kee-joon Choi | 140 | 2016-11-29 | 2026-06-25 |
Death, Sudden, Cardiac (3) · Angina Pectoris, Variant (1) · Arrhythmias, Cardiac (1) · Asphyxia (1) · Birth Weight (1) · Brain Death (1) · Cardiomyopathies (1) · Epilepsies, Myoclonic (1) · Epilepsy (1) · Heart Failure (1) · Hemorrhagic Stroke (1) · Hypotension (1) · Hypoxia-Ischemia, Brain (1) · Intracranial Aneurysm (1) · Ischemic Stroke (1)
Pathologic Processes (7) · Pathological Conditions, Signs and Symptoms (7) · Cardiovascular Diseases (5) · Death, Sudden (4) · Brain Diseases (3) · Central Nervous System Diseases (3) · Heart Arrest (3) · Heart Diseases (3) · Nervous System Diseases (3) · Signs and Symptoms (3) · Vascular Diseases (3) · Cerebrovascular Disorders (2) · Neurologic Manifestations (2) · Aneurysm (1)
Aspirin (1) · Atorvastatin (1) · Carvedilol (1) · Defibrillators, Implantable (1) · Epinephrine (1) · Fenfluramine (1) · Hydrocortisone (1) · Metoprolol (1) · hydrocortisone hemisuccinate (1)
Duan Chuanzhi (1) · Kee-joon Choi (1) · Medicare Hospital (Pvt) Limited (1) · Semmelweis University (1) · The University of Texas Health Science Center, Houston (1) · Unity Health Toronto (1) · University of Rochester (1)
United States (2) · Canada (1) · China (1) · Hungary (1) · Pakistan (1) · South Korea (1)
Chuanzhi Duan, MD (1) · Kata Kovacs, MD, PhD (1) · Paul Dorian, MD, MSc (1) · Samden Lhatoo, MD, FRCP (1) · Samee A Professor, FRCOG (1) · Steve Lin, MD, MSc (1)
PMID 10634801, PMID 11498461, PMID 22472556, PMID 24462073, PMID 25355814, PMID 26590269, PMID 29146831, PMID 29327999, PMID 30565953, PMID 31352800, PMID 31504418, PMID 33447904, PMID 34991791, PMID 35292570, PMID 36375835, PMID 36700744, PMID 37324979, PMID 38198155, PMID 38719444